Dewmar International BMC Inc (DEWM)

[DewmBoom]

THE CONSORTIUM & TELEMEDICINE

The consortium was responsible for most of the net revenue in 2014 (4.1 millions as shown in recent 8k) and this will be shown to continue in 2015.


a. Sales and Marketing for pharmacies, clinics, and hospitals
b. Matching new patient base with pharmacies, clinics and a healthcare centers
c. Invest in healthcare technologies
d. Invest in innovative practices
e. Invest in high-profit margin diagnostic equipment
f. Improve health care practices performance
g. Invest in CirrusMD, a TELEMEDICINE COMPANY


"One of the greatest occurrences for Dewmar during the final quarter of 2014 was the acquisition of a new subsidiary, Health & Wellness Research Consortium, LLC. I like to refer to it as The Consortium for short. The goal of this company is to develop and implement healthcare sales and marketing strategies for pharmacies, clinics and hospitals in order to help maximize the client’s income earning potential. We, in turn, share in the gain in profitability that our team of consultant helped to generate. The Consortium integrates strategic insight, operational excellence and a deep understanding of our specific target market to deliver results by matching a fertile new patient base with pharmacies, clinics and a variety of healthcare specialty care centers.

Furthermore, the Consortium invests in healthcare technologies, innovative practices and high profit-margin diagnostic equipment while simultaneously creating value through strategic guidance, operational insights, and industry strategy. We provide our partners and clients with the unique insight to drive critical decision making, improve their performance and achieve sustained profitable growth. As shown in the unaudited 8K financials, the Consortium was responsible for millions of dollars of revenue earnings in 2014. Our upcoming audited financials will show that his revenue trend has been sustained throughout 2015.

The Consortium, as well as myself personally, has engaged in a financial investment in CirrusMD, a telemedicine technology that offers patients the ability to securely text message, share images and video chat with doctors over smartphones, tablets and computers. A person can schedule a video appointment anytime, anywhere, or instantly strike up a conversation via text.

Regarding telemedicine and international affairs, I hosted Dr. Maurice Mars, the head of Telehealth for South Africa at the annual Governor’s Export Summit after we both returned the previous day from the American Telemedicine Association National Conference."

http://www.dewmarinternational.com/message-from-the-ceo/

This is one of the most lucrative business function for Dewmar International. Healthcare is getting more complicated, sophisticated, and require highly skilled individuals to improve performance and provide expert guidance for many health care businesses small and large. Furthermore, Telemedicine is the future and can grow to 100s of billions of dollars. As I showed earlier, Telemedicine is expected to grow four folds between 2014 and 2018

Anything below 0.01 is a steal before we hit 0.1 by the end of April, the projected date for 2015 audited financial and Q1 2016 release. Dewmar is transforming itself into two very diverse but very lucrative markets.

Very Very Very Strong Buy